Buy Stocks Easy | About Us

June 27, 2022

EOLS

Buy Evolus, Inc. Stock (symbol: EOLS) Easy Online

Company Name: Evolus, Inc.

Symbol: EOLS

Sector: Health Care

Industry: Major Pharmaceuticals

IPO: 2018

EOLS Current Share Price

Today's EOLS ( Evolus, Inc. ) opening price: $12.5000

Yesterday's EOLS ( Evolus, Inc. ) closing price: $12.4300

Evolus, Inc. Stock ( symbol: EOLS ) Price Chart since IPO (2018):

12 Months Evolus, Inc. Stock ( symbol: EOLS ) Price Chart

Popular Questions about Evolus, Inc. Public Stock ( EOLS )

A: Evolus, Inc. stock symbol (also called stock or share ticker) is EOLS

A: Evolus, Inc. IPO (Initial Public Offering) took place on 2018

A: Evolus, Inc.'s stock (EOLS symbol) price at ther IPO (initial Public Offering) was $12.5000

Q: Is EOLS stock worth buying at the moment?

A: The EOLS stock performance since 2019 are rather disappointing. If you had bought 1 share of Evolus, Inc. stock (symbol: EOLS) at the beginning of 2019, at the opening share price of $16.3500, you would be left with exactly $12.5000 - which means a waste of your money and time. - SHOW ONLY IF equal or loose.

Buy Evolus, Inc. Stock Easy Online

Evolus, Inc. Stock Ticker Price Chart since IPO:

Evolus, Inc. Stock Price Yesterday

Evolus, Inc. Stock Price – Last Week

Evolus, Inc. Stock Price – Last Month

Evolus, Inc. Stock Value Chart – 12 Months

Rate this post

Latest Stock News:

http://www.globenewswire.com/news-release/2019/11/07/1942799/0/en/Evolus-Announces-Pricing-of-Public-Offering-of-Common-Stock.html

Evolus Announces Pricing of Public Offering of Common Stock

NEWPORT BEACH, Calif., Nov. 07, 2019 (GLOBE NEWSWIRE) -- Evolus, ...

http://www.globenewswire.com/news-release/2019/11/06/1942571/0/en/Evolus-Announces-Proposed-Public-Offering-of-Common-Stock.html

Evolus Announces Proposed Public Offering of Common Stock

NEWPORT BEACH, Calif., Nov. 06, 2019 (GLOBE NEWSWIRE) -- Evolus, ...

https://seekingalpha.com/article/4302193-evolus-inc-eols-ceo-david-moatazedi-q3-2019-results-earnings-call-transcript

Evolus, Inc. (EOLS) CEO David Moatazedi on Q3 2019 Results - Earnings Call Transcript

Evolus, Inc. (EOLS) CEO David Moatazedi on Q3 2019 Results - Earnin...

http://www.globenewswire.com/news-release/2019/10/28/1936590/0/en/Evolus-to-Report-Third-Quarter-2019-Financial-Results-and-Provide-a-Business-Update-on-Monday-November-4-2019.html

Evolus to Report Third Quarter 2019 Financial Results and Provide a Business Update on Monday, November 4, 2019

NEWPORT BEACH, Calif., Oct. 28, 2019 (GLOBE NEWSWIRE) -- Evolus, ...

http://www.globenewswire.com/news-release/2019/10/16/1930566/0/en/Evolus-and-Clarion-Medical-Technologies-Announce-First-Shipment-of-Nuceiva-prabotulinumtoxinA-to-Customers-in-Canada.html

Evolus and Clarion Medical Technologies Announce First Shipment of Nuceiva™ (prabotulinumtoxinA) to Customers in Canada

NEWPORT BEACH, Calif. and CAMBRIDGE, Ontario, Oct. 16, 2019 (GLOB...

http://www.globenewswire.com/news-release/2019/10/01/1923403/0/en/Evolus-Receives-Approval-for-Nuceiva-in-the-European-Union.html

Evolus Receives Approval for Nuceiva™ in the European Union

NEWPORT BEACH, Calif., Oct. 01, 2019 (GLOBE NEWSWIRE) -- Evolus, ...

http://www.globenewswire.com/news-release/2019/09/18/1917377/0/en/Evolus-will-Participate-in-Cantor-Global-Healthcare-Conference.html

Evolus will Participate in Cantor Global Healthcare Conference

NEWPORT BEACH, Calif., Sept. 18, 2019 (GLOBE NEWSWIRE) -- Evolus,...

http://www.globenewswire.com/news-release/2019/09/04/1910585/0/en/Evolus-Announces-Successful-Completion-of-the-Jeuveau-Experience-Treatment-J-E-T-Program.html

Evolus Announces Successful Completion of the Jeuveau® Experience Treatment (J.E.T) Program

Jeuveau® Achieves Number Three Unit Share Position1 in the U.S. Wit...

http://www.globenewswire.com/news-release/2019/08/22/1905739/0/en/Evolus-to-Participate-in-Two-Upcoming-Investor-Conferences.html

Evolus to Participate in Two Upcoming Investor Conferences

NEWPORT BEACH, Calif., Aug. 22, 2019 (GLOBE NEWSWIRE) -- Evolus, ...

https://www.youtube.com/watch?v=CLew7DlwU-M

Evolus CEO: This company was designed to compete with the market leader

Jim Cramer chats with Evolus CEO David Moatazedi about the state of...

All right reserved Buy Stocks Easy , 2019.